These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28608802)

  • 1. Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients.
    Dalle Carbonare L; Mottes M; Malerba G; Mori A; Zaninotto M; Plebani M; Dellantonio A; Valenti MT
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28608802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss.
    Lindtner RA; Tiaden AN; Genelin K; Ebner HL; Manzl C; Klawitter M; Sitte I; von Rechenberg B; Blauth M; Richards PJ
    Osteoporos Int; 2014 Mar; 25(3):1151-61. PubMed ID: 23974861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis.
    Dalle Carbonare L; Valenti MT; Zanatta M; Donatelli L; Lo Cascio V
    Arthritis Rheum; 2009 Nov; 60(11):3356-65. PubMed ID: 19877060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post-menopausal osteoporosis.
    Tan W; Sun J; Zhou L; Li Y; Wu X
    J Clin Pharm Ther; 2016 Oct; 41(5):519-23. PubMed ID: 27440710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronic acid in vivo increases in vitro proliferation of rat mesenchymal stromal cells.
    Heino TJ; Alm JJ; Halkosaari HJ; Välimäki VV
    Acta Orthop; 2016 Aug; 87(4):412-7. PubMed ID: 27196705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
    Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
    J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risedronate positively affects osteogenic differentiation of human mesenchymal stromal cells.
    Casado-Díaz A; Santiago-Mora R; Dorado G; Quesada-Gómez JM
    Arch Med Res; 2013 Jul; 44(5):325-34. PubMed ID: 23867791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation.
    Ebert R; Zeck S; Krug R; Meissner-Weigl J; Schneider D; Seefried L; Eulert J; Jakob F
    Bone; 2009 May; 44(5):858-64. PubMed ID: 19442618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition.
    Patntirapong S; Singhatanadgit W; Chanruangvanit C; Lavanrattanakul K; Satravaha Y
    J Oral Pathol Med; 2012 Oct; 41(9):713-20. PubMed ID: 22563819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denosumab versus zoledronic acid in patients previously treated with zoledronic acid.
    Anastasilakis AD; Polyzos SA; Gkiomisi A; Saridakis ZG; Digkas D; Bisbinas I; Sakellariou GT; Papatheodorou A; Kokkoris P; Makras P
    Osteoporos Int; 2015 Oct; 26(10):2521-7. PubMed ID: 25990355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with Bisphosphonate Enhances Osteogenesis of Bone Marrow Mesenchymal Stem Cells.
    Hu L; Wen Y; Xu J; Wu T; Zhang C; Wang J; Du J; Wang S
    Stem Cells Dev; 2017 Jan; 26(2):123-132. PubMed ID: 27736364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner--a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2.
    Koch FP; Merkel C; Al-Nawas B; Smeets R; Ziebart T; Walter C; Wagner W
    J Craniomaxillofac Surg; 2011 Dec; 39(8):562-9. PubMed ID: 21030265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers.
    Anastasilakis AD; Polyzos SA; Efstathiadou ZA; Savvidis M; Sakellariou GT; Papatheodorou A; Kokkoris P; Makras P
    Metabolism; 2015 Oct; 64(10):1291-7. PubMed ID: 26198440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole.
    Brufsky A; Bundred N; Coleman R; Lambert-Falls R; Mena R; Hadji P; Jin L; Schenk N; Ericson S; Perez EA;
    Oncologist; 2008 May; 13(5):503-14. PubMed ID: 18515735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway.
    Tao K; Xiao D; Weng J; Xiong A; Kang B; Zeng H
    Toxicol Lett; 2016 Jan; 240(1):68-80. PubMed ID: 26478571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues.
    Sanvoranart T; Supokawej A; Kheolamai P; U-Pratya Y; Klincumhom N; Manochantr S; Wattanapanitch M; Issaragrisil S
    Biochem Biophys Res Commun; 2014 May; 447(4):580-5. PubMed ID: 24747566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ox-PAPCs in the differentiation of mesenchymal stem cells (MSCs) and Runx2 and PPARγ2 expression in MSCs-like of osteoporotic patients.
    Valenti MT; Garbin U; Pasini A; Zanatta M; Stranieri C; Manfro S; Zucal C; Dalle Carbonare L
    PLoS One; 2011; 6(6):e20363. PubMed ID: 21674037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis repressor with caspase recruitment domain enhances survival and promotes osteogenic differentiation of human osteoblast cells under Zoledronate treatment.
    Hu L; Han J; Yang X; Wang Y; Pan H; Xu L
    Mol Med Rep; 2016 Oct; 14(4):3535-42. PubMed ID: 27573706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine regulates osteogenic differentiation and mineralization of primary adipose-derived stem cells and a bone marrow stromal cell line.
    Su SJ; Chang KL; Su SH; Yeh YT; Shyu HW; Chen KM
    Int J Food Sci Nutr; 2013 Jun; 64(4):429-36. PubMed ID: 23301724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Polygonatum sibiricum polysaccharide on the osteogenic differentiation of bone mesenchymal stem cells in mice.
    Zong S; Zeng G; Zou B; Li K; Fang Y; Lu L; Xiao D; Zhang Z
    Int J Clin Exp Pathol; 2015; 8(6):6169-80. PubMed ID: 26261494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.